MicroRNA-15a Carried by Mesenchymal Stem Cell-Derived Extracellular Vesicles Inhibits the Immune Evasion of Colorectal Cancer Cells by Regulating the KDM4B/HOXC4/PD-L1 Axis
Open Access
- 1 March 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
Abstract
The relevance of microRNA-15a (miR-15a) to autoimmunity has been reported. Herein, we intended to probe the potential roles of miR-15a shuttled by adipose-derived mesenchymal stem cells (adMSCs)-derived extracellular vesicles (Evs) in colorectal cancer (CRC). Initially, CRC cells were treated with interferon gamma (IFN-γ) to screen out differentially expressed genes by transcriptome sequencing. Following a 24-h co-culture with 20 μM adMSCs-derived Evs, CRC cell viability, migration, invasion, and apoptosis were assessed. After the determination of histone lysine demethylase 4B (KDM4B) as our target, its regulatory miRNA was predicted by the bioinformatics websites and verified by dual-luciferase and RNA pull-down assays. Intriguingly, KDM4B downregulated homeobox C4 (HOXC4) expression, while HOXC4 bound to the promoter sequence of programmed death-ligand 1 (PD-L1). Thus, we conducted rescue experiments to study the role of KDM4B and HOXC4. Finally, we evaluated the effects of adMSCs on CRC cell growth and immune evasion through in vivo tumorigenesis experiments. AdMSCs-derived Evs overexpressing miR-15a repressed proliferation, migration, and invasion, while it promoted the apoptosis of CRC cells via downregulation of KDM4B. These in vivo findings were reproduced in vitro on CRC immune evasion. Collectively, adMSCs-derived Evs overexpressing miR-15a restricted the immune evasion of CRC via the KDM4B/HOXC4/PD-L1 axis.This publication has 35 references indexed in Scilit:
- IFN-γ from lymphocytes induces PD-L1 expression and promotes progression of ovarian cancerBritish Journal of Cancer, 2015
- Cytotoxic activity of sunitinib and everolimus in Caki-1 renal cancer cells is accompanied by modulations in the expression of apoptosis-related microRNA clusters and BCL2 family genesBiomedicine & Pharmacotherapy, 2015
- miR‐491‐5p functions as a tumor suppressor by targeting JMJD2B in ERα‐positive breast cancerFEBS Letters, 2015
- Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-β and suppress the growth of MCF-7 human breast cancer cellsCancer Letters, 2014
- Mesenchymal stromal cells for organ transplantationCurrent Opinion in Organ Transplantation, 2014
- JMJD2B Promotes Epithelial–Mesenchymal Transition by Cooperating with β-Catenin and Enhances Gastric Cancer MetastasisClinical Cancer Research, 2013
- KDM4/JMJD2 Histone Demethylases: Epigenetic Regulators in Cancer CellsCancer Research, 2013
- Management of colon cancer: resource-stratified guidelines from the Asian Oncology Summit 2012The Lancet Oncology, 2012
- Histone Demethylases KDM4B and KDM6B Promotes Osteogenic Differentiation of Human MSCsCell Stem Cell, 2012
- Histone demethylase JMJD2B coordinates H3K4/H3K9 methylation and promotes hormonally responsive breast carcinogenesisProceedings of the National Academy of Sciences of the United States of America, 2011